Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In the phase 2 dose-escalation study (Jastreboff et al., NEJM, 2023), gastrointestinal adverse events were reported in a substantial proportion of participants, with incidence increasing at higher doses
Hims starts at $199+ but no longer offers tirzepatide after its March 2026 Novo Nordisk settlement
"Unapproved versions do not undergo the FDAs review for safety, effectiveness and quality before they are marketed." The American Diabetes Association's Obesity Association recently published new standards of care that does not recommend the use of non-FDA-approved compounded products
Nothing severe, just some queasiness after larger meals
Appetite Regulation: GLP-1 acts on the brain to help regulate appetite and promote a feeling of fullness, which can reduce overall calorie consumption
What actually happens when you stop
US$ 24.22
US$ 21.19
US$ 27.85
US$ 21.84
US$ 25.15
US$ 27.35
US$ 26.10
